tetano
Editor, Senior Moderator
Rev Soc Bras Med Trop
. 2021 Nov 12;54:e0385.
doi: 10.1590/0037-8682-0385-2021. eCollection 2021.
Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report
Bruno Thizon Menegali[SUP] 1 2 [/SUP], Fabiana Schuelter-Trevisol[SUP] 1 2 [/SUP], Alexandre Naime Barbosa[SUP] 3 [/SUP], Talita Menegali Izidoro[SUP] 2 [/SUP], Otto Henrique May Feurschuette[SUP] 2 [/SUP], Chaiana Esmeraldino Mendes Marcon[SUP] 1 2 [/SUP], Daisson José Trevisol[SUP] 1 2 [/SUP]
Affiliations
Abstract
The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to report a case of passive anti-SARS-CoV-2 immunity in a newborn through immunoprophylaxis of a pregnant woman who received the CoronaVac® vaccine in the third trimester of pregnancy. Twenty-four hours after delivery, samples were collected from the newborn and screened by enzyme immunoassays, which revealed antibodies to SARS-CoV-2.
. 2021 Nov 12;54:e0385.
doi: 10.1590/0037-8682-0385-2021. eCollection 2021.
Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report
Bruno Thizon Menegali[SUP] 1 2 [/SUP], Fabiana Schuelter-Trevisol[SUP] 1 2 [/SUP], Alexandre Naime Barbosa[SUP] 3 [/SUP], Talita Menegali Izidoro[SUP] 2 [/SUP], Otto Henrique May Feurschuette[SUP] 2 [/SUP], Chaiana Esmeraldino Mendes Marcon[SUP] 1 2 [/SUP], Daisson José Trevisol[SUP] 1 2 [/SUP]
Affiliations
- PMID: 34787263
- DOI: 10.1590/0037-8682-0385-2021
Abstract
The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to report a case of passive anti-SARS-CoV-2 immunity in a newborn through immunoprophylaxis of a pregnant woman who received the CoronaVac® vaccine in the third trimester of pregnancy. Twenty-four hours after delivery, samples were collected from the newborn and screened by enzyme immunoassays, which revealed antibodies to SARS-CoV-2.